rs199476335
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PM4_Supporting
The NM_033337.3(CAV3):c.290_292delTCT(p.Phe97del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_033337.3 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAV3 | NM_033337.3 | c.290_292delTCT | p.Phe97del | disruptive_inframe_deletion | Exon 2 of 2 | ENST00000343849.3 | NP_203123.1 | |
CAV3 | NM_001234.5 | c.290_292delTCT | p.Phe97del | disruptive_inframe_deletion | Exon 2 of 3 | NP_001225.1 | ||
OXTR | XR_007095681.1 | n.1885-3099_1885-3097delAAG | intron_variant | Intron 4 of 4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAV3 | ENST00000343849.3 | c.290_292delTCT | p.Phe97del | disruptive_inframe_deletion | Exon 2 of 2 | 1 | NM_033337.3 | ENSP00000341940.2 | ||
CAV3 | ENST00000397368.2 | c.290_292delTCT | p.Phe97del | disruptive_inframe_deletion | Exon 2 of 3 | 1 | ENSP00000380525.2 | |||
CAV3 | ENST00000472766.1 | n.155+11711_155+11713delTCT | intron_variant | Intron 1 of 2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1Other:1
- -
- -
Elevated circulating creatine kinase concentration Pathogenic:1
- -
Rippling muscle disease 2 Pathogenic:1
- -
Caveolinopathy Uncertain:1
Based on the classification scheme VCGS_Germline_v1.3.5, this variant is classified as a VUS-3A. Following criteria are met: 0104 - Dominant negative is a known mechanism of disease in this gene and is associated with caveolinopathy (MONDO:0016146). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity. The same mutation can lead to heterogeneous clinical phenotypes and muscle histopathological changes (PMID: 19584897). (I) 0213 - In-frame deletion in a non-repetitive region that has high conservation. (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (v2, v3 and v4). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v4; 2 heterozygotes, 0 homozygotes). (I) 0600 - Variant is located in the annotated caveolin family domain (DECIPHER). (I) 0705 - No comparable in-frame deletion variants have previous evidence for pathogenicity. (I) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individual. The variant is reported to be present in six affected individuals from the same family with elevated creatine kinase and variable muscle involvement (PMID: 14663034). (SP) 0901 - This variant has strong evidence for segregation with disease. This variant segregates within a large single family (PMID: 14663034). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at